Advertisement

3 Biotech

, 9:19 | Cite as

High-yield expression in Escherichia coli, biophysical characterization, and biological evaluation of plant toxin gelonin

  • Guo-Bin Ding
  • Gengfeng Wu
  • Binchun Li
  • Peng Yang
  • Zhuoyu Li
Original Article
  • 34 Downloads

Abstract

Gelonin is a plant toxin that exerts potent cytotoxic activity by inactivation of the 60S ribosomal subunit. The high-level expression of soluble gelonin still remains a great challenge and there was no detailed biophysical analysis of gelonin from Escherichia coli (E. coli) yet. In this study, the soluble and high-yield expression of recombinant gelonin (rGel) was achieved in E. coli BL21 (DE3) for the first time, with a yield of 6.03 mg/L medium. Circular dichroism (CD) analysis indicated that rGel consisted of 21.7% α-helix, 26.3% β-sheet, 18.5% β-turn, and 32.3% random coil, and it could maintain its secondary structure up to 60 °C. The antitumor activity of rGel was evaluated in two colon cancer cell lines—HCT116 and HCT-8, and it was clearly demonstrated that rGel exerted antiproliferative activity against these two cell lines by inhibiting cellular protein synthesis. These findings provide insights for researchers involved in the expression of similar biotoxins, and the biophysical characterizations of gelonin will favor its further therapeutic applications.

Keywords

Gelonin High-yield expression Biophysical characterization E. coli Biological evaluation 

Notes

Acknowledgements

This study was supported by the National Natural Science Foundation of China (No. 31500771) and “1331 Project” Key Innovation Team of Shanxi Province (Prof. Zhuoyu Li). The authors would like to thank Dr. Yaoming Liu from Scientific Instrument Center of Shanxi University for his helpful discussion in CD characterizations.

Compliance with ethical standards

Conflict of interest

The authors declare no conflict of interests.

Supplementary material

13205_2018_1559_MOESM1_ESM.docx (307 kb)
Supplementary material 1 (DOCX 306 KB)

References

  1. Ajji PK, Sonkar SP, Walder K, Puri M (2018) Purification and functional characterization of recombinant balsamin, a ribosome-inactivating protein from Momordica balsamina. Int J Biol Macromol 114:226–234CrossRefGoogle Scholar
  2. Bai Y, Gou M, Yi T, Yang L, Liu L, Lin X, Su D, Wei Y, Zhao X (2015) Efficient inhibition of ovarian cancer by gelonin toxin gene delivered by biodegradable cationic heparin-polyethyleneimine nanogels. Int J Med Sci 12:397–406CrossRefGoogle Scholar
  3. Berstad MB, Cheung LH, Berg K, Peng Q, Fremstedal AS, Patzke S, Rosenblum MG, Weyergang A (2015) Design of an EGFR-targeting toxin for photochemical delivery: in vitro and in vivo selectivity and efficacy. Oncogene 34:5582–5592CrossRefGoogle Scholar
  4. Bolognesi A, Bortolotti M, Maiello S, Battelli MG, Polito L (2016) Ribosome-inactivating proteins from plants: a historical overview. Molecules 21:1627CrossRefGoogle Scholar
  5. Chang CD, Lin PY, Chen YC, Huang HH, Shih WL (2017) Novel purification method and antibiotic activity of recombinant Momordica charantia MAP30. 3 Biotech 7(3):3CrossRefGoogle Scholar
  6. Cheng G, Li W, Ha L, Han X, Hao S, Wan Y, Wang Z, Dong F, Zou X, Mao Y, Zheng SY (2018) Self-assembly of extracellular vesicle-like metal-organic framework nanoparticles for protection and intracellular delivery of biofunctional proteins. J Am Chem Soc 140:7282–7291Google Scholar
  7. Counterman AE, Thompson MS, Clemmer DE (2003) Identifying a protein by MALDI-TOF mass spectrometry: an experiment for the undergraduate laboratory. J Chem Educ 80:177–180CrossRefGoogle Scholar
  8. Daubenfeld T, Hossann M, Trommer WE, Niedner-Schatteburg G (2005) On the contentious sequence and glycosylation motif of the ribosome inactivating plant protein gelonin. Biochem Biophys Res Commun 333:984–989CrossRefGoogle Scholar
  9. Ding GB, Liu HY, Lv YY, Liu XF, Guo Y, Sun CK, Xu L (2012) Enhanced in vitro antitumor efficacy and strong anti-cell-migration activity of a hydroxycamptothecin-encapsulated magnetic nanovehicle. Chem A Eur J 18:14037–14046Google Scholar
  10. Ding GB, Wang Y, Guo Y, Xu L (2014) Integrin αvβ3-targeted magnetic nanohybrids with enhanced antitumor efficacy, cell cycle arrest ability, and encouraging anti-cell-migration activity. ACS Appl Mater Interfaces 6:16643–16652Google Scholar
  11. Ding GB, Sun J, Yang P, Li B, Gao Y, Li Z (2018a) A novel doxorubicin prodrug with GRP78 recognition and nucleus-targeting ability for safe and effective cancer therapy. Mol Pharm 15:238–246CrossRefGoogle Scholar
  12. Ding GB, Sun J, Wu G, Li B, Yang P, Li Z, Nie G (2018b) Robust anticancer efficacy of a biologically synthesized tumor acidity-responsive and autophagy-inducing functional beclin 1. ACS Appl Mater Interfaces 10:5227–5239Google Scholar
  13. Greenfield NJ (2006) Using circular dichroism spectra to estimate protein secondary structure. Nat Protoc 1:2876–2890Google Scholar
  14. Ham S, Min KA, Yang JW, Shin MC (2017) Fusion of gelonin and anti-insulin-like growth factor-1 receptor (IGF-1R) affibody for enhanced brain cancer therapy. Arch Pharm Res 40:1094–1104CrossRefGoogle Scholar
  15. Hossann M, Li Z, Shi Y, Kreilinger U, Büttner J, Vogel PD, Yuan J, Wise JG, Trommer WE (2006) Novel immunotoxin: a fusion protein consisting of gelonin and an acetylcholine receptor fragment as a potential immunotherapeutic agent for the treatment of Myasthenia gravis. Protein Expr Purif 46:73–84CrossRefGoogle Scholar
  16. Ioannou JC, Donald AM, Tromp RH (2015) Characterising the secondary structure changes occurring in high density systems of BLG dissolved in aqueous pH 3 buffer. Food Hydrocoll 46:216–225CrossRefGoogle Scholar
  17. Li CH, Nguyen X, Narhi L, Chemmalil L, Towers E, Muzammil S, Gabrielson J, Jiang Y (2011) Applications of circular dichroism (CD) for structural analysis of proteins: qualification of near- and far-UV CD for protein higher order structural analysis. J Pharm Sci 100:4642–4654Google Scholar
  18. Mohammadzadeh R, Agheshlouie M, Mahdavinia GR (2017) Expression of chitinase gene in BL21 pET system and investigating the biocatalystic performance of chitinase-loaded AlgSep nanocomposite beads. Int J Biol Macromol 104:1664–1671CrossRefGoogle Scholar
  19. Pal B, Bajpai PK (1998) Spectroscopic characterization of gelonin—assignments secondary structure and thermal denaturation. Indian J Biochem Biophys 35:166–171Google Scholar
  20. Pirie CM, Liu DV, Wittrup KD (2013) Targeted cytolysins synergistically potentiate cytoplasmic delivery of gelonin immunotoxin. Mol Cancer Ther 12:1774–1782CrossRefGoogle Scholar
  21. Puri M, Kaur I, Perugini MA, Gupta RC (2012) Ribosome-inactivating proteins: current status and biomedical applications. Drug Discov Today 17:774–783CrossRefGoogle Scholar
  22. Rosano GL, Ceccarelli EA (2014) Recombinant protein expression in Escherichia coli: advances and challenges. Front Microbiol 5:172PubMedPubMedCentralGoogle Scholar
  23. Shin MC, Zhang J, David AE, Trommer WE, Kwon YM, Min KA, Kim JH, Yang VC (2013) Chemically and biologically synthesized CPP-modified gelonin for enhanced anti-tumor activity. J Controlled Release 172:169–178CrossRefGoogle Scholar
  24. Shin MC, Zhang J, Min KA, Lee K, Moon C, Balthasar JP, Yang VC (2014) Combination of antibody targeting and PTD-mediated intracellular toxin delivery for colorectal cancer therapy. J Controlled Release 194:197–210CrossRefGoogle Scholar
  25. Shin MC, Zhao J, Zhang J, Huang Y, He H, Wang M, Min KA, Yang VC (2015) Recombinant TAT–gelonin fusion toxin: synthesis and characterization of heparin/protamine-regulated cell transduction. J Biomed Mater Res Part A 103:409–419CrossRefGoogle Scholar
  26. Shin MC, Min KA, Cheong H, Moon C, Huang Y, He H, Yang VC (2016) Preparation and characterization of gelonin–melittin fusion biotoxin for synergistically enhanced anti-tumor activity. Pharm Res 33:2218–2228CrossRefGoogle Scholar
  27. Stirpe F (2006) Ribosome-inactivating proteins: progress and problems. Cell Mol Life Sci 63:1850–1866CrossRefGoogle Scholar
  28. Stirpe F (2013) Ribosome-inactivating proteins: from toxins to useful proteins. Toxicon 67:12–16CrossRefGoogle Scholar
  29. Stirpe F, Olsnes S, Pihl A (1980) Gelonin, a new inhibitor of protein synthesis, nontoxic to intact cells. J Biol Chem 255:6947–6953Google Scholar
  30. Turek M, Krzyczmonik M, Balczewski P (2016) New hopes in cancer battle—a review of new molecules and treatment strategies. Med Chem 12:700–719CrossRefGoogle Scholar
  31. Wei Y, Thyparambil AA, Latour RA (2014) Protein helical structure determination using CD spectroscopy for solutions with strong background absorbance from 190 to 230 nm. Biochim Biophys Acta Proteins Proteom 1844:2331–2337CrossRefGoogle Scholar
  32. Woodhams J, Lou PJ, Selbo PK, Mosse A, Oukrif D, MacRobert A, Novelli M, Peng Q, Berg K, Bown SG (2010) Intracellular re-localisation by photochemical internalisation enhances the cytotoxic effect of gelonin—quantitative studies in normal rat liver. J Controlled Release 142:347–353CrossRefGoogle Scholar
  33. Ye J, Shin MC, Liang Q, He H, Yang VC (2015) 15 years of ATTEMPTS: a macromolecular drug delivery system based on the CPP-mediated intracellular drug delivery and antibody targeting. J Controlled Release 205:58–69CrossRefGoogle Scholar

Copyright information

© King Abdulaziz City for Science and Technology 2019

Authors and Affiliations

  1. 1.Institute of Biotechnology, The Key Laboratory of Chemical Biology and Molecular Engineering of Ministry of EducationShanxi UniversityTaiyuanChina
  2. 2.Institutes of Biomedical SciencesShanxi UniversityTaiyuanChina
  3. 3.School of Life ScienceShanxi UniversityTaiyuanChina

Personalised recommendations